Meta-analytic Cross-Sectional Epidemiological Study
Meta-Analysis of Cross-Sectional Epidemiological Studies · Also known as: pooled cross-sectional meta-analysis, prevalence meta-analysis, cross-sectional systematic review with meta-analysis, epidemiological prevalence synthesis
A meta-analytic cross-sectional epidemiological study systematically identifies and statistically pools prevalence or proportion estimates from multiple independent cross-sectional surveys. By combining data across studies — often using variance-stabilising transformations and random-effects models — it produces a more precise and generalisable estimate of disease burden, risk-factor frequency, or health behaviour prevalence in a defined population.
Read the full method
Sign in with a free account to read this section.
When to use it
Use this design when you need a precise, evidence-synthesised estimate of the prevalence or frequency of a condition, exposure, or behaviour across multiple populations or settings, and when the primary studies are cross-sectional in nature. It is particularly appropriate for global or regional burden-of-disease analyses, surveillance summaries, and health planning where multiple local surveys exist but no single study is large enough to be definitive. Do not use it when primary studies vary so widely in outcome definitions or measurement instruments that pooling would be clinically meaningless, when heterogeneity is extreme and unexplained, or when the research question concerns causation rather than frequency — cross-sectional data cannot establish temporal order and a different synthesis design (e.g., meta-analysis of cohort or case-control studies) is needed for etiological questions.
Strengths & limitations
- Produces a more precise pooled prevalence estimate than any single study, especially when individual studies have small samples.
- Random-effects modelling accounts for genuine between-study variability, making results more credible for heterogeneous populations.
- Subgroup and meta-regression analyses can explain how prevalence varies by region, age, sex, diagnostic criterion, or time period.
- Systematic search and PRISMA reporting make the evidence base transparent and reproducible.
- Directly informs public health policy, resource allocation, and clinical guideline development.
- Cross-sectional primary studies capture prevalence at a single point in time, so the pooled estimate cannot address incidence or causal direction.
- High between-study heterogeneity (I-squared > 75%) may make a single pooled estimate misleading even with random-effects modelling.
- Publication bias — journals preferentially publishing extreme or significant prevalence estimates — can inflate or skew the pooled result.
- Quality of the synthesis is bounded by the quality of the primary studies; if most cross-sectional surveys used non-probability sampling, the pooled estimate may not be representative.
- Variance-stabilising transformations (e.g., arcsine) can be difficult to interpret and back-transformation may introduce small errors near extremes.
Frequently asked
Why is the arcsine transformation needed and can I skip it?
Raw proportions bounded near 0 or 1 have non-normal sampling distributions and heteroscedastic variances, which violate the assumptions of standard inverse-variance meta-analysis. The Freeman-Tukey double arcsine transformation stabilises the variance across the full range of proportions. Skipping it when many primary-study proportions are extreme (below 10% or above 90%) can produce biased pooled estimates and misleading confidence intervals. For proportions comfortably between 20% and 80%, logit transformation is a reasonable alternative.
Should I use a fixed-effect or random-effects model?
For prevalence meta-analyses across different populations, settings, and time periods, a random-effects model is almost always appropriate because true prevalence is expected to vary across contexts. A fixed-effect model assumes all studies estimate exactly the same underlying prevalence, which is rarely plausible in epidemiology. The DerSimonian-Laird estimator is the most common random-effects approach, though restricted maximum likelihood (REML) is preferred when the number of studies is large.
How should I handle very high heterogeneity (I-squared > 75%)?
High I-squared does not automatically invalidate the meta-analysis, but it does mean the pooled estimate should be interpreted cautiously. Conduct pre-specified subgroup analyses (by region, diagnostic criterion, age group, study quality) to explore sources of heterogeneity. Meta-regression can test whether study-level covariates explain between-study variance. If heterogeneity remains unexplained and is very large, presenting subgroup-specific estimates rather than a single pooled figure is more informative and honest.
Is this design suitable for studying causation?
No. Pooling cross-sectional data provides frequency estimates, not causal evidence. Cross-sectional studies measure exposure and outcome simultaneously, so they cannot establish which came first. For causal or associational questions, a meta-analysis of cohort, case-control, or randomised studies is required. The meta-analytic cross-sectional design answers 'How common is X?' rather than 'Does A cause B?'
What quality appraisal tool should I use for the included cross-sectional studies?
The Joanna Briggs Institute (JBI) Critical Appraisal Checklist for Prevalence Studies and the AHRQ quality assessment tool for observational studies are both widely used and specifically adapted for cross-sectional designs. The Newcastle-Ottawa Scale adapted for cross-sectional studies is another option. Whichever tool is chosen, quality scores should inform sensitivity analyses rather than be used as a simple exclusion threshold.
Sources
- Barendregt, J. J., Doi, S. A., Lee, Y. Y., Norman, R. E., & Vos, T. (2013). Meta-analysis of prevalence. Journal of Epidemiology and Community Health, 67(11), 974-978. DOI: 10.1136/jech-2013-203104 ↗
- Higgins, J. P. T., Thomas, J., Chandler, J., Cumpston, M., Li, T., Page, M. J., & Welch, V. A. (Eds.). (2019). Cochrane Handbook for Systematic Reviews of Interventions (2nd ed.). Wiley-Blackwell. ISBN: 978-1119536956
How to cite this page
ScholarGate. (2026, June 3). Meta-Analysis of Cross-Sectional Epidemiological Studies. ScholarGate. https://scholargate.app/en/epidemiology/meta-analytic-cross-sectional-epidemiological-study